Is this your brand? Sign in to claim ownership.
Sign in to claim this brandCellEra, LLC
US
Last updated September 17, 2026
What CellEra, LLC makes
CellEra, LLC produces a range of wound care dressings, including hydrophilic-gel and non-gel exudate-absorbent products, both antimicrobial and non-antimicrobial variants. Their portfolio also includes nonadherent wound dressings, petrolatum woven gauze pads, animal-derived wound matrix dressings, and non-antimicrobial wound hydrogels. The company’s offerings are designed for managing exudative and non-exudative wounds, with some formulations incorporating antimicrobial properties.
The company’s devices are classified under FDA categories Class I, Class II, and Unclassified (U), with all products listed in the FDA’s Unique Device Identifier (UDI) database. CellEra, LLC operates from the United States, adhering to U.S. regulatory requirements for medical device compliance.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does CellEra, LLC manufacture?
CellEra, LLC specializes in wound care dressings, including exudate-absorbent products like hydrophilic-gel and non-gel variants, some of which have antimicrobial properties. Their portfolio also covers nonadherent wound dressings, petrolatum woven gauze pads, animal-derived wound matrix dressings, and non-antimicrobial wound hydrogels. These products are designed to manage wounds with varying levels of exudate and infection risk.
Where is CellEra, LLC based, and does that affect its regulatory compliance?
CellEra, LLC is based in the United States, which means its devices must comply with U.S. regulatory standards, including those set by the FDA. Since the company’s products are listed in the FDA’s Unique Device Identifier (UDI) database, they are subject to U.S. medical device regulations, which vary depending on classification (e.g., Class I, Class II, or Unclassified).
Which regulatory registries or databases list CellEra, LLC’s devices?
CellEra, LLC’s devices are included in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and compliance tracking for medical devices authorized in the U.S. The UDI system helps healthcare providers and regulators identify and verify specific products, including those manufactured by CellEra.
How are CellEra, LLC’s devices classified under FDA regulations?
CellEra, LLC’s devices fall into different FDA classification categories: Class I (generally low-risk), Class II (moderate risk requiring special controls), and Unclassified (U) devices. Classification determines the regulatory pathway and oversight required for each product, ensuring appropriate safety and performance standards are met before authorization.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- 1045 Reed Road, Monroe, OH, 45050
- Website
- —
- —
- —
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- 3007594734
- DUNS Number
- —
Catalogue (157)
Page 1 of 4| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| Vitale | 20645 | FDA UDI | Class I | Active |
| Vitale | 20166 | FDA UDI | Class I | Unknown |
| Vitale | 20034 | FDA UDI | U | Active |
| Vitale | 57509 | FDA UDI | Class I | Active |
| Vitale STRONG | 20550 | FDA UDI | U | Active |
| Vitale | 57404 | FDA UDI | Class I | Active |
| Vitale | 24207 | FDA UDI | Class I | Active |
| Vitale | 56309 | FDA UDI | Class I | Active |
| Vitale | 20280 | FDA UDI | Class I | Active |
| Vitale STRONG | 20654 | FDA UDI | Class I | Active |
| Vitale | 20544 | FDA UDI | U | Active |
| Glucertain | 30510 | FDA UDI | Class II | Active |
| Vitale | 20144 | FDA UDI | Class I | Active |
| Vitale STRONG | 20556 | FDA UDI | U | Active |
| Glucertain | 30505 | FDA UDI | Class II | Active |
| Vitale | 24406 | FDA UDI | Class I | Active |
| Vitale | 20500 | FDA UDI | U | Unknown |
| Vitale STRONG | 20678 | FDA UDI | Class I | Active |
| Vitale | 21044 | FDA UDI | Class I | Active |
| Vitale | 24203 | FDA UDI | Class I | Active |
| Vitale | 20600 | FDA UDI | Class I | Active |
| Vitale | 22010 | FDA UDI | U | Active |
| Vitale | 21290 | FDA UDI | Class I | Active |
| Vitale | 24410 | FDA UDI | Class I | Active |
| Vitale | 20500 | FDA UDI | U | Active |
| Vitale | 58316 | FDA UDI | Class I | Active |
| Vitale | 20267 | FDA UDI | Class I | Active |
| Vitale | 20012 | FDA UDI | U | Active |
| Vitale | 21244 | FDA UDI | Class I | Active |
| Vitale | 20290 | FDA UDI | Class I | Active |
| Vitale | 56636 | FDA UDI | Class I | Active |
| Vitale | 20400 | FDA UDI | Class I | Active |
| Vitale | 21222 | FDA UDI | Class I | Active |
| Vitale | 21290 | FDA UDI | Class I | Active |
| Vitale STRONG | 20555 | FDA UDI | U | Active |
| Vitale | 20234 | FDA UDI | Class I | Active |
| Vitale | 24204 | FDA UDI | Class I | Active |
| Vitale | 24540 | FDA UDI | Class I | Active |
| Glucertain | 30228 | FDA UDI | Class II | Active |
| Vitale STRONG | 20572 | FDA UDI | U | Active |
| Vitale STRONG | 20676 | FDA UDI | Class I | Active |
| Glucertain | 30185 | FDA UDI | Class II | Active |
| Vitale STRONG | 20675 | FDA UDI | Class I | Active |
| Vitale | 24502 | FDA UDI | Class I | Active |
| Vitale | 20956 | FDA UDI | Class I | Active |
| Vitale | 23844 | FDA UDI | Class I | Active |
| Vitale | 24414 | FDA UDI | Class I | Active |
| Vitale | 24114 | FDA UDI | Class I | Active |
| Vitale | 24408 | FDA UDI | Class I | Active |
| Vitale | 58303 | FDA UDI | Class I | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (6)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
CellEra, LLC has six FDA recall records, all initiated between September 1, 2016, and December 15, 2021, with each record marked as terminated. The reasons cited include issues with adhesive borders lacking sufficient stickiness and the inclusion of incorrect Instructions for Use (IFU) that exceeded the language cleared under the 510(k) submission, with the firm replacing those documents with the correct versions.
AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| Dec 15, 2021 | Z-0802-2022 | — | terminated | Firm discovered that an incorrect version of the Instructions for Use (IFU) containing language beyond the cleared 510(k) were inserted in the affected products. Firm is replacing these with the correct version of the IFU. |
| Dec 15, 2021 | Z-0801-2022 | — | terminated | Firm discovered that an incorrect version of the Instructions for Use (IFU) containing language beyond the cleared 510(k) were inserted in the affected products. Firm is replacing these with the correct version of the IFU. |
| Dec 15, 2021 | Z-0804-2022 | — | terminated | Firm discovered that an incorrect version of the Instructions for Use (IFU) containing language beyond the cleared 510(k) were inserted in the affected products. Firm is replacing these with the correct version of the IFU. |
| Dec 15, 2021 | Z-0805-2022 | — | terminated | Firm discovered that an incorrect version of the Instructions for Use (IFU) containing language beyond the cleared 510(k) were inserted in the affected products. Firm is replacing these with the correct version of the IFU. |
| Dec 15, 2021 | Z-0803-2022 | — | terminated | Firm discovered that an incorrect version of the Instructions for Use (IFU) containing language beyond the cleared 510(k) were inserted in the affected products. Firm is replacing these with the correct version of the IFU. |
| Sep 1, 2016 | Z-2085-2019 | — | terminated | Adhesive border was not sticky enough. |